ProMetic, American Red Cross and Macopharma to Market the First Product for the Selective Adsorbtion of Prions out from Blood
Initial European roll out planned for 2005 - Strategic alliance to include development of filters for viruses - MacoPharma to market and distribute the products
03-Aug-2004 -
Pathogen Removal and Diagnostic Technologies Inc. (PRDT), the
joint venture company of ProMetic Life Sciences Inc. and the
American Red Cross, announced today the formation of a strategic alliance with
MacoPharma, one of the largest distributors of blood collection bag sets with
complementary ...
filters
Formation
hepatitis C
+5